What innovative features could MSD add to its Gardasil HPV vaccine to increase adoption rates among young adults?

Introduction

To increase adoption rates of Gardasil HPV vaccine among young adults, we need to explore innovative features that address barriers to vaccination and enhance the overall user experience. I'll analyze the current landscape, identify key user segments, pinpoint pain points, and propose creative solutions to drive adoption. Let's begin by clarifying some crucial aspects of the problem.

Step 1

Clarifying Questions

• Looking at the product context, I'm thinking about the current adoption rates and barriers. Could you provide more information on the current adoption rates among young adults and the primary reasons for hesitation?

Why it matters: This helps us understand the scale of the problem and identify specific areas to target. Expected answer: Adoption rates are around 50% for young adults, with common barriers including cost, lack of awareness, and concerns about safety. Impact on approach: Would focus on addressing these specific barriers in our solution.

• Considering user behavior, I'm curious about the decision-making process for vaccination. How do young adults typically learn about and decide to get the HPV vaccine?

Why it matters: Understanding the user journey helps us identify key touchpoints for intervention. Expected answer: Many learn about it from healthcare providers or school programs, but social media and peer influence play a significant role. Impact on approach: Would explore digital engagement strategies and peer-to-peer advocacy features.

• Examining external factors, I'm wondering about the competitive landscape. Are there other HPV vaccines in the market, and how does Gardasil compare in terms of efficacy and side effects?

Why it matters: This helps us understand Gardasil's unique selling points and areas for differentiation. Expected answer: Gardasil is the market leader with high efficacy, but there are concerns about potential side effects. Impact on approach: Would focus on highlighting Gardasil's benefits while addressing safety concerns.

• Thinking about company alignment, what are MSD's broader objectives for Gardasil beyond increasing adoption rates?

Why it matters: Ensures our proposed solutions align with the company's overall strategy. Expected answer: MSD aims to position Gardasil as a key player in global HPV prevention and expand into new markets. Impact on approach: Would consider features that support global scalability and market expansion.